Virus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infection
about
Biomimetic and synthetic interfaces to tune immune responsesToward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challengesRecent advances in engineering polyvalent biological interactionsGlycotherapy: new advances inspire a reemergence of glycans in medicineSweeten PAMPs: Role of Sugar Complexed PAMPs in Innate Immunity and Vaccine Biology.Site-Specific Glycoconjugation of Protein via Bioorthogonal Tetrazine Cycloaddition with a Genetically Encoded trans-Cyclooctene or Bicyclononyne.Realizing the Promise of Chemical Glycobiology.Selective chemical protein modification.Recent Developments in Synthetic Carbohydrate-Based Diagnostics, Vaccines, and Therapeutics.Synthetic multivalency for biological applications.Sugared biomaterial binding lectins: achievements and perspectives.Polyvalent display of monosaccharides on ferritin protein cage nanoparticles for the recognition and binding of cell-surface lectins.C-type lectins: their network and roles in pathogen recognition and immunity.Myeloid C-Type Lectin Receptors in Viral Recognition and Antiviral Immunity.Dissecting Multivalent Lectin-Carbohydrate Recognition Using Polyvalent Multifunctional Glycan-Quantum Dots.Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Multivalent Protein-Ligand Interactions.Glycofullerenes: Sweet fullerenes vanquish viruses.Monitoring the Disassembly of Virus-like Particles by 19F-NMR.Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Multivalent Protein-Ligand Interactions.Human dendritic cell activation induced by a permannosylated dendron containing an antigenic GM3-lactone mimetic.Piperidine-based glycodendrons as protein N-glycan prosthetics.Postsynthetic functionalization of glycodendrons at the focal point.Chemical protein synthesis (CPS) meeting 2013.One-Step Derivatization of Reducing Oligosaccharides for Rapid and Live-Cell-Compatible Chelation-Assisted CuAAC Conjugation.pH and glucose responsive nanofibers for the reversible capture and release of lectins.Selective carbohydrate–lectin interactions in covalent graphene- and SWCNT-based molecular recognition systemsAntiviral activity of self-assembled glycodendro[60]fullerene monoadductsPolyvalent C-glycomimetics based on l-fucose or d-mannose as potent DC-SIGN antagonistsSynthesis of giant globular multivalent glycofullerenes as potent inhibitors in a model of Ebola virus infectionGlycodendritic structures: tools to interact with DC-SIGN
P2860
Q26801229-1DF6A214-1D82-4C8A-9AA8-41DF3D8ABBC1Q26995399-803BB43C-BEEC-4D92-9186-668505DF4B66Q27011503-F1009B01-7C77-4E62-B988-7B1EF41EA253Q27027997-B1A2C598-3794-4259-9396-6F6B302FF1AFQ34370741-048267A6-FF29-4A6B-A799-EB6B2BF91324Q36358330-68AB0F83-B432-47A0-9DFA-5E9DFE55B87BQ37063821-D9A9F365-E926-4B05-A7FB-7964219A7FDAQ38246195-AD400E33-2D58-428E-A320-52753FDB5BD0Q38533442-65DA556F-C744-4A61-A3D9-E6A2A6ACB3EEQ38598783-0F110802-E8D4-42B8-9689-EFE55B163EE8Q38807532-E765445B-2177-4E0A-BB8A-937E46FE2240Q39025143-82F7B4DA-08D2-4050-8E8C-36464548993DQ39045109-35346D30-A732-4F2C-B305-2C1EB1CCBA1EQ39192653-9CB5753A-BA9A-402B-BCAB-0109E2401841Q40044194-668835B2-0528-44F9-92DB-269B3E732027Q40091292-730D6131-6B81-4757-958E-9275BDC8C2E4Q40126790-1D57493B-DE62-49B2-8B25-CDA4A912575CQ40270477-4479A8CB-921F-4B3F-BF49-D756D1657162Q40750350-CAF121BB-6C71-4EBE-B76D-B56274F8C708Q41587909-0C38B22C-2340-4B14-AB82-EA1C68DD3E7FQ42387014-45633EE5-09A0-4CFA-8F65-92A056926860Q42837630-6DDAC43F-E91D-4EE3-B7E2-C57F15A78D62Q46010823-8E45909B-B000-4A93-907B-546B26E983FFQ48245292-38D65718-210D-4690-B120-A4C8F8EA782DQ51832735-DCAD733D-2F9E-41E9-82B4-2758DCEA83A7Q57615973-B1A7E417-D6B4-4B08-8857-5E31F1B27D60Q58328174-CEF0EE79-BAC7-4AFC-819E-F26E29058134Q58328175-AD248634-9862-441F-89D0-34CA06C7B56AQ58328180-3E0CB380-11CF-46DB-A41B-A9ED0E9CEF25Q58328186-4CCE5982-AAE6-45E2-9B15-F80D1D48C327
P2860
Virus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infection
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Virus-like glycodendrinanopart ...... potently block viral infection
@ast
Virus-like glycodendrinanopart ...... potently block viral infection
@en
type
label
Virus-like glycodendrinanopart ...... potently block viral infection
@ast
Virus-like glycodendrinanopart ...... potently block viral infection
@en
prefLabel
Virus-like glycodendrinanopart ...... potently block viral infection
@ast
Virus-like glycodendrinanopart ...... potently block viral infection
@en
P2093
P2860
P50
P356
P1476
Virus-like glycodendrinanopart ...... potently block viral infection
@en
P2093
Benjamin G Davis
Julia R Koeppe
Rafael Delgado
Renato Ribeiro-Viana
P2860
P2888
P356
10.1038/NCOMMS2302
P407
P577
2012-01-01T00:00:00Z
P5875
P6179
1021225961